Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: mAbTree Biologics AG
January 22, 2026
mAbTree Biologics AG
Orphan Drug Designation
treatment of polycythemia vera
Disease Area:
Rare Disease
Source
Source
January 1, 2026
mAbTree Biologics AG
Orphan Drug Designation
FDA orphan drug designation: treatment of essential thrombocythemia
Disease Area:
Rare Diseases
Source
Source
Scroll to Top
